Back to Search
ROBIN TITUS, MD
MD
Family Medicine Physician
NPI: 1467428870Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
4617(NV)
Research & Publications (20)
Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis.
PMID 19597544·PLoS Negl Trop Dis·2009
7-preclinical
Lutzomyia longipalpis salivary peptide maxadilan alters murine dendritic cell expression of CD80/86, CCR7, and cytokine secretion and reprograms dendritic cell-mediated cytokine release from cultures containing allogeneic T cells.
PMID 18523295·J Immunol·2008
4-observational
Objective evaluation of skin prick test reactions using digital photography.
PMID 17374055·Skin Res Technol·2007
8-other
Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice.
PMID 17360887·Am J Trop Med Hyg·2007
7-preclinical
Immunomodulatory effects of the Lutzomyia longipalpis salivary gland protein maxadilan on mouse macrophages.
PMID 17339357·Infect Immun·2007
7-preclinical
Effect of Lutzomyia longipalpis salivary gland extracts on leukocyte migration induced by Leishmania major.
PMID 17255235·Am J Trop Med Hyg·2007
7-preclinical
Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania.
PMID 18165522·Am J Trop Med Hyg·2007
7-preclinical
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) reduces Leishmania major burdens in C57BL/6 mice.
PMID 17038706·Am J Trop Med Hyg·2006
7-preclinical
Salivary gland extracts of Culicoides sonorensis inhibit murine lymphocyte proliferation and no production by macrophages.
PMID 16968936·Am J Trop Med Hyg·2006
7-preclinical
Nanodisk-associated amphotericin B clears Leishmania major cutaneous infection in susceptible BALB/c mice.
PMID 16569834·Antimicrob Agents Chemother·2006
7-preclinical
The immunomodulatory factors of arthropod saliva and the potential for these factors to serve as vaccine targets to prevent pathogen transmission.
PMID 16542315·Parasite Immunol·2006
6-review
Novel compounds active against Leishmania major.
PMID 16436699·Antimicrob Agents Chemother·2006
7-preclinical
The human cytokine response to Leishmania major early after exposure to the parasite in vitro.
PMID 15270099·J Parasitol·2004
7-preclinical
Characterization of the early cellular immune response to Leishmania major using peripheral blood mononuclear cells from Leishmania-naive humans.
PMID 15569786·Am J Trop Med Hyg·2004
7-preclinical
Immunization with Leishmania major exogenous antigens protects susceptible BALB/c mice against challenge infection with L. major.
PMID 15385463·Infect Immun·2004
7-preclinical
Characterization of an I-E-restricted, gp63-specific, CD4-T-cell clone from Leishmania major-resistant C3H mice that secretes type 2 cytokines and exacerbates infection with L. major.
PMID 15271907·Infect Immun·2004
7-preclinical
Lutzomyia longipalpis salivary gland homogenate impairs cytokine production and costimulatory molecule expression on human monocytes and dendritic cells.
PMID 14977931·Infect Immun·2004
7-preclinical
Infection with Leishmania major stimulates haematopoiesis in susceptible BALB/c mice and suppresses haematopoiesis in resistant CBA mice.
PMID 12666877·Parasitology·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 213 S WHITACRE ST
YERINGTON, NV 89447 - Phone
- (775) 463-2301
Quick Facts
- NPI
- 1467428870
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile